English
Leave Your Message
High-Quality Cabiralizumab Biosimilar: Anti-CSF1R mab- Research Grade

Antibody

High-Quality Cabiralizumab Biosimilar: Anti-CSF1R mab- Research Grade

  • Catalog number: ADT1110
  • Host species: CHO Cells
  • Application: ELISA, IHC, IF, IP, Flow Cyt, Inhibition
  • Target: CSF1R/CD115[Homo sapiens]

CSF1R inhibitionitors have been developed as a potential route to reduce the presence of TAMs in the tumor microenvironment. As of 2017, CSF1R inhibitionitors that are currently in early stage clinical trials include Pexidartinib, PLX7486, ARRY-382, JNJ-40346527, BLZ945, Emactuzumab, AMG820, IMC-CS4, MCS110, and Cabiralizumab.

Alpha Lifetech is proud to offer biosimilar antibodies product, Cabiralizumab Biosimilar, designed to revolutionize the treatment of various research conditions. Our Cabiralizumab Biosimilar antibody product is manufactured using biotechnological processes, ensuring high purity, potency, and consistency in every batch. Alpha Lifetech adheres to stringent quality control measures throughout the production process, guaranteeing the safety and efficacy of our biosimilar antibody product. Choose Alpha Lifetech’s biosimilar antibody product for a reliable, effective, and cost-efficient treatment.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

CSF1R, also known as macrophage colony-stimulating factor receptor (M-CSFR) and CD115 (Cluster of Differentiation 115), is a receptor for hematopoietic growth factor called CSF1. Binding of CSF1R to its ligand CSF1R, regulates the proliferation, differentiation, and survival of various cells including monocytes, macrophages, bone marrow progenitor cells and earlier hematopoietic progenitors. The mutation of CSF1R is related to chronic myelomonocytic leukemia and type M4 acute myeloblastic leukemia.

Product Specification

Catalog Number

ADT1110

Product Name

High-Quality Cabiralizumab Biosimilar: Anti-CSF1R mab- Research Grade

Tags

biosimilar antibodies, biosimilar monoclonal antibodies, Cabiralizumab Biosimilar, Cabiralizumab, CSF1R/CD115, Anti-CSF1R,1613144-80-1

CAS Number

1613144-80-1

Target

CSF1R/CD115[Homo sapiens]

Molecular Weigh

149.15 KDa

Alias

FPA-008

Isotype

IgG4 Kappa

Host

CHO Cells

Clonity

Monoclonal

Research area

Cancer

Application

ELISA, IHC, IF, IP, Flow Cyt, Inhibition

Size

100ug,1mg,5mg

Concentration

batch dependent

Buffer

Supplied in PBS, PH7.5

Purity

>95% as determined by SDS-PAGE

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage. Avoid repeated freezing and thawing.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only.

FAQ

Leave Your Message